| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
22,900,000 |
| Market
Cap: |
29.54(M) |
| Last
Volume: |
145,865 |
Avg
Vol: |
145,472 |
| 52
Week Range: |
$1.275 - $3.61 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Computer Hardware |
| Level
III Sector: |
Computer Peripherals |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ COMPUTER |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile iCAD is a medical technology company providing cancer detection and therapy solutions. Co.'s segments are: Cancer Detection, which includes image analysis and workflow solutions that enable healthcare personnel to identify pathologies and pinpoint prevalent cancers earlier, and various Artificial Intelligence and Computer-Aided Detection systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography; and Cancer Therapy, which provides the Xoft Axxent Electronic Brachytherapy System, an isotope-free cancer treatment platform technology for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
38,960 |
| Total Sell Value |
$0 |
$0 |
$0 |
$106,653 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sallam Maha |
Director |
– • – |
2010-03-12 |
4 |
S |
$1.44 |
$867 |
D/D |
(600) |
1,087,087 |
|
- |
|
| Sallam Maha |
Director |
– • – |
2010-03-11 |
4 |
S |
$1.42 |
$9,133 |
D/D |
(6,409) |
1,087,687 |
|
- |
|
| Deptula-Hicks Darlene M |
Executive VP of Finance, CFO |
• – – |
2010-03-11 |
4 |
S |
$1.40 |
$27,481 |
D/D |
(19,629) |
141,184 |
|
- |
|
| Deptula-Hicks Darlene M |
Executive VP of Finance, CFO |
• – – |
2010-03-10 |
4 |
S |
$1.40 |
$7,239 |
D/D |
(5,170) |
160,813 |
|
- |
|
| Deptula-Hicks Darlene M |
Executive VP of Finance, CFO |
• – – |
2010-03-09 |
4 |
S |
$1.41 |
$283 |
D/D |
(201) |
165,983 |
|
- |
|
| Sallam Maha |
Director |
– • – |
2010-03-08 |
4 |
S |
$1.44 |
$13,431 |
D/D |
(9,327) |
1,094,096 |
|
- |
|
| Sallam Maha |
Director |
– • – |
2010-03-05 |
4 |
S |
$1.44 |
$518 |
D/D |
(360) |
1,103,423 |
|
- |
|
| Sallam Maha |
Director |
– • – |
2010-03-04 |
4 |
S |
$1.44 |
$451 |
D/D |
(313) |
1,103,783 |
|
- |
|
| Deptula-Hicks Darlene M |
Exec VP of Finance, CFO |
• – – |
2010-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
166,184 |
|
- |
|
| Ferry Kenneth M |
President, CEO |
• • – |
2010-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
838,000 |
|
- |
|
| Stevens Stacey M |
Sr VP of Marketing & Strategy |
• – – |
2010-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
222,093 |
|
- |
|
| Go Jonathan |
Senior VP of R&D |
• – – |
2010-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
110,000 |
|
- |
|
| Barnes Jeffrey H |
Exec VP of Commercial Operatio |
• – – |
2010-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
260,093 |
|
- |
|
| Sallam Maha |
Director |
– • – |
2010-01-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
1,104,096 |
|
- |
|
| Sallam Maha |
Director |
– • – |
2009-12-28 |
4 |
D |
$1.36 |
$45,000 |
D/D |
(33,088) |
1,114,096 |
|
- |
|
| Sallam Maha |
Director |
– • – |
2009-12-28 |
4 |
OE |
$0.80 |
$45,000 |
D/D |
56,250 |
1,147,184 |
|
- |
|
| Sallam Maha |
Director |
– • – |
2009-12-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
1,090,934 |
|
- |
|
| Sallam Maha |
Director |
– • – |
2009-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
1,105,934 |
|
- |
|
| Howard Dr Lawrence |
Director |
– • – |
2009-12-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
57,000 |
|
- |
|
| Howard Dr Lawrence |
Director |
– • – |
2009-12-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
1,500,853 |
|
- |
|
| Sallam Maha |
Director |
– • – |
2009-11-04 |
4 |
AS |
$1.81 |
$9,417 |
D/D |
(5,208) |
1,117,601 |
|
- |
|
| Sallam Maha |
Director |
– • – |
2009-11-03 |
4 |
AS |
$1.80 |
$7,240 |
D/D |
(4,022) |
1,122,809 |
|
- |
|
| Barnes Jeffrey H |
ExecVP ofCommercial Operations |
• – – |
2009-10-13 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
215,093 |
|
- |
|
| Sallam Maha |
Director |
– • – |
2009-10-01 |
4 |
AS |
$2.07 |
$20,724 |
D/D |
(10,000) |
1,126,831 |
|
- |
|
| Sallam Maha |
Director |
– • – |
2009-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,667) |
1,115,934 |
|
- |
|
459 Records found
|
|
Page 12 of 19 |
|
|
0.02 (1.53%) 
